Treatment for Panic Disorder with Agoraphobia

Psychotherapy Options

Cognitive-behavioral therapy (CBT) has demonstrated significant efficacy in reducing panic frequency, avoidance behavior, anxiety sensitivity, and associated depressive symptoms in patients with panic disorder with agoraphobia, according to the Journal of Anxiety Disorders 2, 3, 4
The American Academy of Child and Adolescent Psychiatry recommends CBT as the first-line treatment for panic disorder with agoraphobia, with selective serotonin reuptake inhibitors (SSRIs) as the preferred pharmacological option when medication is indicated 1
Diaphragmatic breathing techniques and interoceptive exposure to feared bodily sensations are key components of effective CBT for panic disorder with agoraphobia 5

If there is inadequate response to SSRIs, serotonin-norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine can be considered as a second-line option, as suggested by the Praxis Medical Insights 6
High-potency benzodiazepines (alprazolam, clonazepam) may be useful for short-term treatment due to their rapid onset of action, but are not recommended for long-term management due to risk of dependence, according to the Praxis Medical Insights 6

Treatment may need cultural adaptations for optimal efficacy, with African American patients benefiting from CBT that addresses cultural issues, with particular emphasis on in vivo exposure components, as found in the Journal of Anxiety Disorders 2, 3, 4
Studies have shown that while both African American and European American patients show improvement with CBT, treatment outcomes may differ, with 54% of African American patients classified as recovered and 17% as improved with culturally-tailored CBT, according to the Journal of Anxiety Disorders 4

The initial treatment should begin with CBT as first-line treatment, consisting of 12-15 sessions, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 1
If inadequate response to initial treatment, consider switching to an SNRI like venlafaxine, as suggested by the Praxis Medical Insights 6

Using benzodiazepines as sole first-line treatment due to risk of dependence and tolerance development, as warned by the Praxis Medical Insights 6
Failing to address cultural factors that may influence symptom presentation and treatment response, as emphasized by the Journal of Anxiety Disorders 2, 3, 4
Neglecting to use standardized assessment tools to monitor treatment progress, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 1, 7